Avadel Pharmaceuticals (AVDL) Deferred Taxes (2019 - 2022)
Historic Deferred Taxes for Avadel Pharmaceuticals (AVDL) over the last 4 years, with Q4 2022 value amounting to -$51.9 million.
- Avadel Pharmaceuticals' Deferred Taxes fell 29245.96% to -$51.9 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$26.0 million, marking a year-over-year decrease of 26612.41%. This contributed to the annual value of -$26.0 million for FY2022, which is 26612.41% down from last year.
- Per Avadel Pharmaceuticals' latest filing, its Deferred Taxes stood at -$51.9 million for Q4 2022, which was down 29245.96% from $46000.0 recorded in Q3 2022.
- In the past 5 years, Avadel Pharmaceuticals' Deferred Taxes ranged from a high of $30.2 million in Q2 2022 and a low of -$51.9 million during Q4 2022
- In the last 4 years, Avadel Pharmaceuticals' Deferred Taxes had a median value of -$394500.0 in 2019 and averaged $212875.0.
- As far as peak fluctuations go, Avadel Pharmaceuticals' Deferred Taxes crashed by 370180.18% in 2020, and later surged by 91735.25% in 2022.
- Avadel Pharmaceuticals' Deferred Taxes (Quarter) stood at $5.0 million in 2019, then soared by 140.21% to $12.0 million in 2020, then skyrocketed by 124.66% to $27.0 million in 2021, then tumbled by 292.46% to -$51.9 million in 2022.
- Its last three reported values are -$51.9 million in Q4 2022, $46000.0 for Q3 2022, and $30.2 million during Q2 2022.